The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Assembly, Trafficking and Function of γ-Secretase
Abstract
γ-Secretase catalyzes the final cleavage of the β-amyloid precursor protein to generate amyloid-β peptide, the principal component of amyloid plaques in the brains of patients suffering from Alzheimer’s disease. Here, we review the identification of γ-secretase as a protease complex and its assembly and trafficking to its site(s) of cellular function. In reconstitution experiments, γ-secretase was found to be composed of four integral membrane proteins, presenilin (PS), nicastrin (NCT), PEN-2 and APH-1 that are essential and sufficient for γ-secretase activity. PS, which serves as a catalytic subunit of γ-secretase, was identified as a prototypic member of novel aspartyl proteases of the GxGD type. In human cells, γ-secretase could be further defined as a heterogeneous activity consisting of distinct complexes that are composed of PS1 or PS2 and APH-1a or APH-1b homologues together with NCT and PEN-2. Using green fluorescent protein as a reporter we localized PS and γ-secretase activity at the plasma membrane and endosomes. Investigation of γ-secretase complex assembly in knockdown and knockout cells of the individual subunits allowed us to develop a model of complex assembly in which NCT and APH-1 first stabilize PS before PEN-2 assembles as the last component. Furthermore, we could map domains in PS and PEN-2 that govern assembly and trafficking of the complex. Finally, Rer1 was identified as a PEN-2-binding protein that serves a role as an auxiliary factor for γ-secretase complex assembly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is considerable evidence that the functional γ-secretase four-subunit complex is assembled following ER exit [223,228,229].”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [229]
In the citing paper
“The amyloid precursor protein (APP) undergoes sequential cleavages by the rate limiting b-secretase (BACE1) and c-secretase originating mainly Ab40 and Ab42 [2,3].”
From Bin1 and CD2AP polarise the endocytic generation of beta‐amyloid (2017) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · cited 1×
“Identification of γ-Secretase Ten years ago, a handful of mutations causing early-onset familial AD (FAD) were discovered and mapped to two novel genes located on chromosomes 1 and 14 [”
BackgroundScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818 · cited 1×
“The number of mutations found increased rapidly to more than 150 in 2005, including 144 PS1 mutations. PS1 is therefore the major gene responsible for early-onset FAD. The finding that FAD-associated mutants shifted the cleavage specificity of γ-secretase towards Aβ42 formation suggested that PSs might be modulators o…”
BackgroundWolfe, M. S., Xia, W., Moore, C. L., Leatherwood, D. D., Ostaszewski, B., Rahmati, T., Donkor, I. O., & Selkoe, D. J. (1999) · Biochemistry · doi:10.1021/bi982562p · Cited by 289
Research works printed but not linked: 65
- 10.1126%2Fscience.1072994 · DOI · Paper page
- 10.1038%2Fsj.emboj.7600061 · DOI · Paper page
- 10.2174%2F1567205043332081 · DOI
- 10.1126%2Fscience.7638621 · DOI · Paper page
- 10.1074%2Fjbc.M507217200 · DOI · Paper page
- 10.1152%2Fajpcell.00636.2004 · DOI
- 10.1111%2Fj.1742-4658.2005.04691.x · DOI
- 10.1016%2FS0896-6273%2800%2980291-3 · DOI · Paper page
- 10.1038%2F377351a0 · DOI · Paper page
- 10.1038%2F19077 · DOI · Paper page
- 10.1074%2Fjbc.274.40.28669 · DOI · Paper page
- 10.1021%2Fbi991453n · DOI
- 10.1038%2F35015085 · DOI · Paper page
- 10.1038%2F35017062 · DOI · Paper page
- 10.1074%2Fjbc.275.2.1502 · DOI · Paper page
- 10.1126%2Fscience.1070925 · DOI · Paper page
- 10.1074%2Fjbc.M501645200 · DOI
- 10.1016%2FS0962-8924%2802%2902394-2 · DOI · Paper page
- 10.1073%2Fpnas.94.10.5090 · DOI
- 10.1074%2Fjbc.273.6.3205 · DOI · Paper page
- 10.1074%2Fjbc.273.26.16470 · DOI · Paper page
- 10.1073%2Fpnas.110126897 · DOI · Paper page
- 10.1074%2Fjbc.272.45.28415 · DOI · Paper page
- 10.1074%2Fjbc.273.48.32322 · DOI · Paper page
- 10.1038%2F35024009 · DOI · Paper page
- 10.1016%2FS1534-5807%2802%2900189-2 · DOI · Paper page
- 10.1073%2Fpnas.022523499 · DOI · Paper page
- 10.1074%2Fjbc.C200469200 · DOI · Paper page
- 10.1074%2Fjbc.M208164200 · DOI · Paper page
- 10.1038%2Fncb960 · DOI · Paper page
- 10.1074%2Fjbc.M305834200 · DOI
- 10.1073%2Fpnas.1037392100 · DOI · Paper page
- 10.1038%2Fnature01506 · DOI · Paper page
- 10.1111%2Fj.1471-4159.2004.02447.x · DOI
- 10.1016%2Fj.nbd.2004.08.002 · DOI
- 10.1038%2Fnm0296-224 · DOI · Paper page
- 10.1016%2FS0166-2236%2899%2901455-1 · DOI
- 10.1083%2Fjcb.200201123 · DOI · Paper page
- 10.1074%2Fjbc.M409272200 · DOI · Paper page
- 10.1074%2Fjbc.M304009200 · DOI · Paper page
- 10.1074%2Fjbc.M401789200 · DOI
- 10.1074%2Fjbc.C300095200 · DOI
- 10.1074%2Fjbc.C200648200 · DOI · Paper page
- 10.1074%2Fjbc.C200148200 · DOI · Paper page
- 10.1074%2Fjbc.M406228200 · DOI
- 10.1074%2Fjbc.M309745200 · DOI
- 10.1111%2Fj.1471-4159.2005.03165.x · doi:10.1111/j.1471-4159.2005.03165.x
- 10.1074%2Fjbc.M406289200 · DOI
- 10.1074%2Fjbc.C400396200 · DOI
- 10.1074%2Fjbc.C300435200 · DOI
- 10.1074%2Fjbc.M305685200 · DOI
- 10.1038%2Fsj.emboj.7600478 · DOI
- 10.1074%2Fjbc.M407717200 · DOI
- 10.1074%2Fjbc.M509070200 · DOI
- 10.1074%2Fjbc.M509066200 · DOI
- 10.1074%2Fjbc.M409106200 · DOI
- 10.1091%2Fmbc.E02-12-0777 · DOI
- 10.1111%2Fj.1471-4159.2005.03099.x · DOI
- 10.1074%2Fjbc.274.12.7615 · DOI
- 10.1038%2F35008626 · DOI
- 10.1093%2Femboj%2Fcdf541 · DOI · Paper page
- 10.1074%2Fjbc.M206872200 · DOI · Paper page
- 10.1074%2Fjbc.M413969200 · DOI
- 10.1016%2FS1097-2765%2800%2900061-7 · DOI · Paper page
- 10.1016%2Fj.cell.2005.05.022 · DOI · Paper page
Cited by
Trafficking and Proteolytic Processing of APP
Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006270 · Cited by 1,075
Self-citationHistory and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy
McGeer, P. L., & McGeer, E. G. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1177-7 · Cited by 467
The chemistry of Alzheimer’s disease
Rauk, A. (2009) · Chemical Society Reviews · doi:10.1039/b807980n · Cited by 417
Cell and molecular biology of Notch
Fiúza, U.-M., & Arias, A. M. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0242 · Cited by 371
Salomone, S., Caraci, F., Leggio, G. M., Fedotova, J., & Drago, F. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04134.x · Cited by 309
Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin
Rosales‐Corral, S. A., Acuña‐Castroviejo, D., Coto‐Montes, A., Boga, J. A., Manchester, L. C., Fuentes‐Broto, L., Korkmaz, A., Ma, S., Tan, D. X., & Reiter, R. J. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00937.x · Cited by 294
Zhang, Z., Song, M., Liu, X., Su Kang, S., Duong, D. M., Seyfried, N. T., Cao, X., Cheng, L., Sun, Y. E., Ping Yu, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9762 · Cited by 277
Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review
Minati, L., Edginton, T., Grazia Bruzzone, M., & Giaccone, G. (2009) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317508328602 · Cited by 268
Alzheimer's disease: the lipid connection
Hartmann, T., Kuchenbecker, J., & Grimm, M. O. W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04715.x · Cited by 175
Colacurcio, D. J., Pensalfini, A., Jiang, Y., & Nixon, R. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.001 · Cited by 167
Bin1 and CD2AP polarise the endocytic generation of beta‐amyloid
Ubelmann, F., Burrinha, T., Salavessa, L., Gomes, R., Ferreira, C., Moreno, N., & Guimas Almeida, C. (2017) · The EMBO Reports · doi:10.15252/embr.201642738 · Cited by 165
Wnt/β-Catenin Signaling in Alzheimer’s Disease
Ferrari, G., Avila, M., Medina, M., Perez-Palma, E., Bustos, B., & Alarcon, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527312666131223113900 · Cited by 95
Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells
Brunholz, S., Sisodia, S., Lorenzo, A., Deyts, C., Kins, S., & Morfini, G. (2012) · Experimental Brain Research · doi:10.1007/s00221-011-2870-1 · Cited by 92
Synaptic Autoregulation by Metalloproteases and γ-Secretase
Restituito, S., Khatri, L., Ninan, I., Mathews, P. M., Liu, X., Weinberg, R. J., & Ziff, E. B. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2513-11.2011 · Cited by 70
Selective Secretase Targeting for Alzheimer’s Disease Therapy
Miranda, A., Montiel, E., Ulrich, H., & Paz, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201027 · Cited by 66
Toh, W. H., & Gleeson, P. A. (2016) · Biochemical Journal · doi:10.1042/bcj20160147 · Cited by 62
Baranger, K., Bonnet, A. E., Girard, S. D., Paumier, J.-M., García-González, L., Elmanaa, W., Bernard, A., Charrat, E., Stephan, D., Bauer, C., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00163 · Cited by 44
Escamilla-Ayala, A. A., Sannerud, R., Mondin, M., Poersch, K., Vermeire, W., Paparelli, L., Berlage, C., Koenig, M., Chavez-Gutierrez, L., Ulbrich, M. H., et al. (2020) · eLife · doi:10.7554/elife.56679 · Cited by 29
Wang, J., Fourriere, L., & Gleeson, P. A. (2024) · Biochemical Journal · doi:10.1042/bcj20240056 · Cited by 27
MicroRNA-Target Interaction Regulatory Network in Alzheimer’s Disease
Turk, A., Kunej, T., & Peterlin, B. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121275 · Cited by 20
Reduced Aβ secretion by human neurons under conditions of strongly increased BACE activity
Scholz, D., Chernyshova, Y., Ückert, A., & Leist, M. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14467 · Cited by 11
Trasviña-Arenas, C. H., Ayala Medina, L. A., & Vique-Sanchez, J. L. (2023) · Reports of Biochemistry and Molecular Biology · doi:10.61186/rbmb.12.2.340 · Cited by 5
Metadata
- Authors
- Kaether, C., Haass, C., & Steiner, H.
- Venue
- Neurodegenerative Diseases
- Publisher
- S. Karger AG
- Published
- 2006
- Volume
- 3
- Issue
- 4-5
- Pages
- 275-283
- ISSN
- 1660-2854
- 1660-2862
- Cited by
- 129
- References
- 6
- Language
- en
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.